UPDATE: MDUFA Passage Approaches

MDUFA Passage approaches:  The House and Senate negotiators reached agreement on the user fee legislative package over the weekend. The bill includes some stronger FDA reforms from the House bill and waters down the FDA reclassification process slightly (gives full streamlined authority for pre-1976 amendment devices, and adds a review panel requirement for all other devices). The bill could be on the House floor as early as Wednesday.

Max Baucus takes early step on tax deal - POLITICO.com

Max Baucus takes early step on tax deal - Seung Min Kim - POLITICO.com: "Sen. Max Baucus (D-Mont.) on Monday began to lay the groundwork for a major tax reform deal, laying out in broad strokes what a sweeping compromise would need to achieve."

Private Insurers Vow to Keep Popular ACA Pieces if Court Strikes Healthcare Bill Down - InsideHealthPolicy.com

Following UnitedHealthcare's Move, Other Insurers Also Vow To Keep Some Popular ACA Pieces: "United Healthcare's announcement that it would keep certain popular health reform provisions regardless of the Supreme Court's decision on the law's constitutionality quickly opened the floodgates for other large insurance companies to take action, with Humana and Aetna making similar announcements Monday (June 11), something that could partially ease Republicans' efforts to come up with an ACA replacement plan."

Healthcare reform beyond the Supreme Court decision-massdevice.com

Healthcare reform beyond the Supreme Court decision-massdevice.com: Healthcare analysts speculate on how medical device makers and other healthcare industries will respond to each of the 3 probable outcomes of the Supreme Court's review of the Affordable Care Act: Affirmation of President Barack Obama's healthcare reform law; abolition of the individual insurance mandate alone; or dissolution of the law altogether.

CBO: U.S. device excise tax repeal would cost $30 billion over 10 years

CBO: U.S. device excise tax repeal would cost $30 billion over 10 years-massdevice.com: Ahead of highly anticipated US Congressional votes to repeal the planned 2.3% medical device excise tax, an analysis by the Congressional Budget Office anticipates $29.1 billion in lost federal revenues through 2022 if the repeal goes into effect.